Laser treatment of glaucoma: Evolution of laser trabeculoplasty techniques

Techniques in Ophthalmology

Volumn 6, Issue 2, 2008, Pages 45-52

  Fea, Antonio M ^a   Dorin, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; STROMELYSIN;

AGE; ARGON LASER; CYTOKINE PRODUCTION; DIODE LASER; EYE SURGERY; GLAUCOMA; HIGH TEMPERATURE; HUMAN; INTRAOCULAR PRESSURE; KAPLAN MEIER METHOD; LASER TRABECULOPLASTY; MICROCAPSULE; OPEN ANGLE GLAUCOMA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; STRESS; THERAPY EFFECT; TRABECULAR MESHWORK; UPREGULATION;

EID: 67650329874     PISSN: 15421929     EISSN: 15421937     Source Type: Journal    
DOI: 10.1097/ITO.0b013e31817dcba2     Document Type: Review

References (51)

1. Worthen DM, Wickam MG. Argon laser trabeculotomy. Trans Am Acad Ophthalmol Otolaryngol. 1974;78: OP371-OP375.
2. Wise JB, Witter SL. Argon laser therapy for open angle glaucoma: a pilot study. Arch Ophthalmol. 1979;97: 319-322.
3. Brancato R, Carassa R, Trabucchi G. Diode laser compared with argon laser trabeculoplasty. Am J Ophthalmol. 1991; 112:50-55.
4. Moriarty A, McHugh D, Spalton D, et al. Comparison of the anterior chamber inflammatory response to diode and argon laser trabeculoplasty using a laser flare meter. Ophthalmology. 1993;100:1263-1267.
5. Chung P, Lloyd-Muhammad R, Netland P, et al. Five Years Results of a Randomized Prospective Clinical Trial of Diode Versus Argon Laser Trabeculoplasty. Chicago: American Academy of Ophthalmology; 1996.
6. Ingvoldstad DD, Krishna R, Willoughby L. Micropulse diode laser trabeculoplasty versus argon laser traculoplasty in the treatment of open angle glaucoma. Invest Ophthmal Vis Sci. 2005;46:ARVO E-Abstract 123.
7. American Academy of Ophthalmology. Committee on Ophthalmic Procedures Assessment. Laser trabeculoplasty for primary open-angle glaucoma. Ophthalmology. 1996; 103:1706-1712.
8. Park CH, Latina MA, Schuman JS. Developments in laser trabeculoplasty. Ophthalmic Surg Lasers. 2000;30: 315-322.
9. Olivier MMG. Glaucoma laser treatment: where are we now? Tech Ophthalmol. 2004; 2:118-123.
10. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial follow-up study: 7. Results. Am J Ophthalmol. 1995;120:718-731.
11. The Advanced Glaucoma Intervention Study 13. Comparison of treatment outcomes within race 10 years results. Ophthalmology. 2004;111:651-664.
12. Musch DC, Lichter PR, Guire KE, et al. for the CIGTS Study Group. The collaborative initial glaucoma treatment study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 1999;106:653-662.
13. Lichter PR, Musch DC, Gillespie BW, et al. for the CIGTS Study Group. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001; 108:1943-1953.
14. Heijl A, Leske MC, Bengtsson B, et al. for the Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression. Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120: 1268-1279.
15. Leske MC, Heijl A, Hussein M, et al. for the Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
16. Bergea B, Svedbergh B. Primary argon laser trabeculoplasty vs pilocarpine. Short term effects. Acta Ophthalmologica. 1992;70:454-460.
17. Gandolfi S, Chetta A, Cimino K, et al. Bronchial reactivity in healthy individuals undergoing long-term treatment with beta-blockers. Arch Ophthal. 2005;123:35-38.
18. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994;101: 1651-1656.
19. Moriarty BJ, Char JN, Acheson RW, et al. Argon laser trabeculoplasty in primary open-angle glaucoma - results in Black Jamaican population. Int Ophthalmol. 1988;12: 217-221.
20. Sherwood MB, Lattimer J, Hitchings RA. Laser trabecu-loplasty as supplementary treatment for primary open angle glaucoma. Br J Ophthalmol. 1987;71:188-191.
21. Jampel HD. Initial treatment for open-angle glaucoma -medical, laser, or surgical? Laser trabeculoplasty is the treatment of choice for chronic open-angle glaucoma. Arch Ophthalmol. 1998;116:240-241.
22. Migdal C, Hitchings R. Primary therapy for chronic simple glaucoma. The role of argon laser trabeculoplasty. Trans Ophthalmol Soc U K. 1985;104:62-66.
23. Shigleton BJ, Richter CU, Dharma SK, et al. Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study. Ophthalmology. 1993;100:1324-1329.
24. Rachmiel R, Trope GE, Chipman ML, et al. Laser trabeculoplasty trends with the introduction of new medical treatments and selective laser trabeculoplasty. J Glaucoma. 2006;15:306-309.
25. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220:524-527.
26. Harasymowycz PJ, Papamatheakis DG, Latina M, et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshwork.Am J Ophtalmol. 2005;139:1110-1113.
27. Damji KF, Shah KC, Rock WJ, et al. Slective laser trabeculoplasty vs argon laser trabeculolasty: a prospective randomized clinical trial. Br J Ophthalmol. 1999;83:718-722.
28. Damij KF, Bovel AM, Hodge WC, et al. Selective laser trabeculoplasty vs argon laser trabeculoplasty: results from a one year randomized clinical trial. Br J Ophthalmol. 2006; 90:1490-1494.
29. Juzych MS, Chopa V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplast vs argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology. 2004;111:1853-1859.
30. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation and postoperative pain. Eye. 2004;19:498-502.
31. Popiela G, Muzyka M, Szelepin L, et al. Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma. Klin Oczna. 2000;102:129-133.
32. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, non-randomized pilot study. Arch Ophthalmol. 2003;121:857-860.
33. McIlraith I, Strasfeld M, Colev G, et al. Selective laser trabeculolasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma. 2006;124-130.
34. Lai JS, Chua JK, Tham CC, Lam DS. Five-year follow-up of selective laser trabeculolasty in Chinese eyes. Clin Experiment Ophthalmol. 2004;32:368-372.
35. Gracner T. Intraocular pressure response of capsular glaucoma and primary open angle glaucoma to selective laser trabeculoplasty: a prospective, comparative clinical trial. Eur J Ophthalmol. 2002;12:287-292.
36. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532 nm Nd-YAG laser trabeculoplasty, a multicenter, pilot, clinical study. Ophthalmology. 1998;105:2082-2090.
37. Hodge WG, Damji KF, Rock W, et al. Baseline IOP predicts selective laser trabeculoplasty success at one year post-treatment: results from a randomized clinical trial. Br J Ophthalmol. 2005;89:1157-1160.
38. Mucciolo JT. The effect of SLT in OAG patients with previous 360° ALT. ARVO. 2003.
39. Caronia RM. The effects of SLT on steroid induced ocular hypertension. ARVO. 2005.
40. Werner M, Smith MF, Doyle JW. Selective laser trabeculoplasty in phakic and pseudophakic eyes. Ophthalmic Surg Lasers Imaging. 2007;38:182-188.
41. Nagar M, Ogunyomade A, O'Bart DP, et al. A randomized, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol. 2005;89:1413-1417.
42. Sliney DH, Marshall J. Tissue specific damage to the retinal pigment epithelium: mechanisms and therapeutic implications. Lasers Light Ophthalmol. 1992;5:17-28.
43. Laursen ML, Moeller F, Sander B, et al. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol. 2004;88:1173-1179.
44. Luttrull JK, Musch DC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol. 2005; 89:74-80.
45. Battaglia Parodi M, Spasse S, Iacono P, et al. Subthreshold grid laser treatment of macular edema secondary to branch retinal vein occlusion with micropulse infrared (810 nanometer) diode laser. Ophthalmology. 2006;113:2237-2242.
46. Siviprasad S, Sandhu R, Tandon A, et al. Subthreshold micropulse diode laser photocoagulation for clinically significant diabetic macular oedema: a three-year follow-up. Clin Experiment Ophthalmol. 2007;35:640-644. doi:10. 1111/j.1442-9071.2007.01566.
47. Mainster MA. Decreasing retinal photocoagulation Damage: principles and techniques. Semin Ophthalmol. 1999; 14:200-209.
48. Lanzetta P, Dorin G, Piracchio A, et al. Theoretical bases of non-ophthalmoscopically visible endpoint photocoagulation. Semin Ophthalmol. 2001;16:8-11.
49. Dorin G. Subthreshold and micropulse diode laser photocoagulation. Semin Ophthalmol. 2003;18:147-153.
50. Fea FM, Bosone R, Rolle T, Brogliatti B, et al. Micropulse diode laser trabeculoplasty (MLDT): a phase II clinical study with 12 months follow-up. Clinical Ophthalmology. 2008 April; Epub ahead of print.
51. Greeidge KC, Spaeth GL, Fiol-Silva Z. Effect of argon laser trabeculoplasty in the glaucomatous diurnal curve. Ophthalmology. 1983;90:800-804.